Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Allarity Therapeutics, Inc. - Common stock (NQ:ALLR)

1.600 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,318
Open 1.600
Bid (Size) 1.590 (14)
Ask (Size) 1.610 (5)
Prev. Close 1.600
Today's Range 1.600 - 1.600
52wk Range 0.6138 - 5.361
Shares Outstanding 365,173,471
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
These stocks have an unusual volume in today's session
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga

Performance

YTD
+44.1%
+44.1%
1 Month
+58.4%
+58.4%
3 Month
+82.0%
+82.0%
6 Month
+78.4%
+78.4%
1 Year
-68.2%
-68.2%

More News

Read More
Top stock movements in today's session.
Via Chartmill
Check out the stocks that are attracting the most attention and driving market activity.
Via Chartmill
Why Did Allarity Therapeutics Stock Double In Value Today?
Via Stocktwits
Power Metallic’s (TSX-V: PNPN | OTCQB: PNPNF) Strategic Appointment Signals Major Paradigm Shift Ahead – More Stocks Inside
Via AB Newswire
Topics Government
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Tuesday's session: top gainers and losers
Via Chartmill
Crude Oil Down 2%; US Durable Goods Orders Decline In July
Via Benzinga
Traders are paying attention to the gapping stocks in Tuesday's session.
Via Chartmill
US Stocks Mixed; American Woodmark Posts Downbeat Sales
Via Benzinga
Tuesday's pre-market session: top gainers and losers
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Allarity Therapeutics Granted FDA Fast Track Designation for Stenoparib for the Treatment of Advanced Ovarian Cancer
From Allarity Therapeutics, Inc.
Via GlobeNewswire
Stock Market Today: S&P 500, Nasdaq Futures Decline— Palo Alto, XP, Allarity Earnings In Focus
Via Benzinga
Topics Stocks
Palo Alto Networks, Fabrinet And 3 Stocks To Watch Heading Into Monday
Via Benzinga
Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships
From Allarity Therapeutics, Inc.
Via GlobeNewswire
This MongoDB Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
Allarity Therapeutics Announces New Licensing and Laboratory Services Agreement to Expand DRP® Platform Utilization
From Allarity Therapeutics, Inc.
Via GlobeNewswire
Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer
From Allarity Therapeutics, Inc.
Via GlobeNewswire
Allarity Therapeutics Receives Australian Patent Acceptance Notice for Stenoparib DRP® Companion Diagnostic
From Allarity Therapeutics, Inc.
Via GlobeNewswire
Allarity Therapeutics Announces Dosing of Second Patient in New Phase 2 Trial of Stenoparib in Advanced Ovarian Cancer
From Allarity Therapeutics, Inc.
Via GlobeNewswire
Allarity Therapeutics Announces Changes to Board of Directors
From Allarity Therapeutics, Inc.
Via GlobeNewswire
Allarity Therapeutics Announces Research Collaboration with Indiana Biosciences Research Institute to Further Advance Understanding of Stenoparib’s Unique, Dual Therapeutic Mechanism of Action
From Allarity Therapeutics, Inc.
Via GlobeNewswire
Allarity Therapeutics Announces First Patient Enrolled in New Phase 2 Clinical Trial Protocol of Stenoparib in Advanced Ovarian Cancer
From Allarity Therapeutics, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Allarity Therapeutics, Inc. - Common stock publicly traded?
Yes, Allarity Therapeutics, Inc. - Common stock is publicly traded.
What exchange does Allarity Therapeutics, Inc. - Common stock trade on?
Allarity Therapeutics, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Allarity Therapeutics, Inc. - Common stock?
The ticker symbol for Allarity Therapeutics, Inc. - Common stock is ALLR on the Nasdaq Stock Market
What is the current price of Allarity Therapeutics, Inc. - Common stock?
The current price of Allarity Therapeutics, Inc. - Common stock is 1.600
When was Allarity Therapeutics, Inc. - Common stock last traded?
The last trade of Allarity Therapeutics, Inc. - Common stock was at 09/02/25 04:00 PM ET
What is the market capitalization of Allarity Therapeutics, Inc. - Common stock?
The market capitalization of Allarity Therapeutics, Inc. - Common stock is 584.28M
How many shares of Allarity Therapeutics, Inc. - Common stock are outstanding?
Allarity Therapeutics, Inc. - Common stock has 584M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.